Outbreak of Multidrug-Resistant Tuberculosis — Kansas, 2021–2022

  01 September 2023

U.S. multidrug-resistant (MDR) tuberculosis (TB) is uncommon and usually occurs in non–U.S.-born persons who likely acquired infection years earlier while living in other countries.

An MDR TB outbreak involving 13 persons with active disease and nine with latent TB infections was identified within four Kansas households in 2021 and included multiple U.S.-born children who became infected in Kansas. One person in a neighboring state with an epidemiologic connection to the Kansas outbreak was identified. Controlling this outbreak required newer MDR TB drugs not often used in the United States.

This outbreak underscores the importance of prompt identification and appropriate treatment of TB disease and latent infection, especially MDR TB.

Further reading: CDC
Author(s): CDC
Effective Surveillance  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS

BD





AMR NEWS

Every two weeks in your inbox

Because there should be one newsletter that brings together all One Health news related to antimicrobial resistance: AMR NEWS!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed